Quick recognition is key to early initiation of treatment and long-term survival.
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high mortality.
Quick action was needed against this very rare cause of fungal endocarditis.
This In the Literature piece considers a fixed-dose strategy for administering daptomycin in obese patients.
What can clinicians do now that increasing resistance has limited oral treatment options for outpatient cystitis?
The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.
The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing had its series of meetings to update breakpoints for a variety of classes of antimicrobials.
For people living with chronic hepatitis D, the latest study results confirm the benefit of injections of this first-in-class entry inhibitor.
In recognition of Lyme disease awareness month, Contagion® interviewed Pat Smith, president of Lyme Disease Association, Inc, to better understand current issues surrounding the diagnosis and treatment of Lyme disease.
Clostridium difficile infection leads to higher rates of overall mortality among patients with cirrhosis compared to those who do not, according to a new study.
There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.
Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.
Dr. Shibani Mukerji discusses how HIV affects the brain as part of a symposium at ID Week 2017.
Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Recognition of chronic Lyme disease and the role of long-term antibiotic treatment for persistent symptoms continue to be controversial among researchers, providers, patients, and advocates.
Kaiser Permanente Northern California’s study shows that the pertussis vaccine weakens as time passes after a patient's most recent vaccination.
The CDC Foundation and the Florida Department of Health have announced that the the Pfizer Foundation has donated millions to improve Zika response efforts.
Relevant existing reports, though limited, demonstrated positive outcomes and suggest a promising space for pharmacy practice growth in outpatient antimicrobial stewardship.
Diagnostic stewardship is a novel concept related to modifying the process of ordering, testing, and reporting with the goal of decreasing unnecessary testing and treatment, working upstream and synergistically with antimicrobial stewardship principles.
Preliminary evidence indicates no direct evidence for intrauterine transmission of the SARS-CoV-2 virus from pregnant women with COVID-19 to their infants.
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.
Contagion® radio is here to bring joy with every new antibiotic alert!
The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.
Updates include novel and revised breakpoints for azithromycin, polymyxins, daptomycin, and cefiderocol.
The global emergence of antimicrobial resistance among gram-negative species is a major public health concern.
The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.